1-2 of 2
Youn C. Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

Clinical Trials & Observations
Jean-Luc Harousseau, Giovanni Martinelli, Wieslaw W. Jedrzejczak, Joseph M. Brandwein, Dominique Bordessoule, Tamas Masszi, Gert J. Ossenkoppele, Julia A. Alexeeva, Gernot Beutel, Johan Maertens, Maria-Belen Vidriales, Hervé Dombret, Xavier Thomas, Alan K. Burnett, Tadeusz Robak, Nuriet K. Khuageva, Anatoly K. Golenkov, Elena Tothova, Lars Mollgard, Youn C. Park, Annick Bessems, Peter De Porre, Angela J. Howes, for the FIGHT-AML-301 Investigators
Journal: Blood
Blood (2009) 114 (6): 1166–1173.
https://doi.org/10.1182/blood-2009-01-198093
Published: 2009
Journal Articles

A Randomized Phase 3 Study of Tipifarnib Compared to Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients 70 Years or Older.

Jean-Luc Harousseau, Giovanni Martinelli, Wieslaw W. Jedrzejczak, Joseph Brandwein, Dominique Bourdessoule, Tamas Masszi, Gert Ossenkoppele, Julia A. Alexeeva, Gernot Beutel, Youn C. Park, Peter De Porre, Angela J. Howes
Journal: Blood
Blood (2007) 110 (11): 439.
https://doi.org/10.1182/blood.V110.11.439.439
Published: 2007